申请人:SMITHKLINE BEECHAM CORPORATION
公开号:EP0162695A1
公开(公告)日:1985-11-27
Compounds of formula (I):
in which R1 is hydrogen or C1-5 alkyl; and R2 and R3 are hydrogen, C1-4 alkyl, phenyl (CH2)n where n is 0-3, C5-6 cycloalkyl or C3-5 alkenyl; intermediates and processes for their preparation, pharmaceutical compositions containing them and their use as selective serotonin receptor antagonists.
式(I)化合物:
其中 R1 为氢或 C1-5 烷基;R2 和 R3 为氢、C1-4 烷基、苯基 (CH2)n(其中 n 为 0-3)、C5-6 环烷基或 C3-5 烯基;制备它们的中间体和工艺、含有它们的药物组合物以及它们作为选择性血清素受体拮抗剂的用途。